Raymond James Financial Services Advisors’s Organogenesis Holdings ORGO Stock Holding History

Raymond James Financial Services Advisors’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-15,000	Closed	-$42.6K	–	3492
2024 Q1	$42.6K	Buy	+15,000	New	+$51K	﹤0.01%	3307
2021 Q4	–	Sell	-215,891	Closed	-$3.07M	–	3407
2021 Q3	$3.07M	Sell	215,891 -8,073	-4%	-$125K	0.01%	1235
2021 Q2	$3.72M	Buy	223,964 +96,475	+76%	+$1.8M	0.01%	1123
2021 Q1	$2.32M	Buy	+127,489	New	+$1.73M	0.01%	1315

Other funds holding ORGO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Raymond James Financial Services Advisors's ORGO Position: Q2 2024 in Review

Raymond James Financial Services Advisors sold out of Organogenesis Holdings (ORGO) in Q2 2024, closing a stake of 15,000 shares — an estimated $42.6K sold.

Raymond James Financial Services Advisors first reported a position in ORGO in Q1 2021 and held it in 4 quarters. The position peaked at $3.72M in Q2 2021. 115 funds tracked by Wall St. Rank hold ORGO as of Q2 2024.

Raymond James Financial Services Advisors reported no remaining Organogenesis Holdings position as of Q2 2024 after selling out during the quarter.
Raymond James Financial Services Advisors sold 15,000 Organogenesis Holdings shares in Q2 2024, an estimated $42.6K.
Raymond James Financial Services Advisors first reported a position in Organogenesis Holdings in Q1 2021 and held it in 4 quarters.
Raymond James Financial Services Advisors's Organogenesis Holdings position peaked at $3.72M in Q2 2021.
115 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q2 2024, filed 19 Jul 2024.